Br J Cancer 1995, 72: 934–938.PubMed 18. Hellström KE, Hellström I: Immunological approaches to tumor therapy. Monoclonal antibodies, tumor vaccines and anti-idiotypes. Targeted Diagn Ther 1989, 2: 1–39. Review.PubMed 19. Salinas FA, Wee KH, Silver HK: Clinical relevance of immune complexes, associated antigen, and antibody in cancer. Contemp Top Immunobiol 1985, 15: 55–109. Review.PubMed 20. Epenetos AA, Britton KE, Mather S, Shepherd J, Granowska M, Taylor-Papadimitriou
J, Nimmon CC, Durbin H, Hawkins LR, Malpas JS, Bodmer WF: Targeting of iodine-123-labelled tumor-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumors. Lancet 1982, 2: 999–1005.CrossRefPubMed 21. Brown A, Ellis IO, Embleton MJ, Baldwin RW, Turner DR, Hardcastle JD: Immunohistochemical localization of Y hapten and the structurally related H type-2 blood-group antigen this website on large-bowel tumors and normal adult tissues. Int J Cancer 1984, 33: 727–736.CrossRefPubMed 22. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227: 680–685.CrossRefPubMed 23. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure Selonsertib solubility dmso and some applications. Proc Natl Acad Sci USA 1979, 76: 4350–4354.CrossRefPubMed 24. Croce MV, Isla Larrain M, Rabassa ME, Demichelis S, Colussi AG, Crespo M, Lacunza E, Segal-Eiras A:
Lewis x is Protein Tyrosine Kinase inhibitor highly expressed in normal tissues: a comparative immunohistochemical study and literature
revision. Pathol Oncol Res 2007, 13: 130–138. Review.CrossRefPubMed 25. Nichols EJ, Kannagi R, Hakomori SI, Krantz MJ, Fuks A: Carbohydrate determinants associated with carcinoembryonic antigen (CEA). J Immunol 1985, 135: 1911–1913.PubMed 26. Fernandes B, Sagman U, Auger M, Demetrio M, Dennis JW: Beta 1–6 branched oligosaccharides as a marker of tumor progression Glutathione peroxidase in human breast and colon neoplasia. Cancer Res 1991, 51: 718–723.PubMed 27. Nemoto-Sasaki Y, Mitsuki M, Morimoto-Tomita M, Maeda A, Tsuiji M, Irimura T: Correlation between the sialylation of cell surface Thomsen-Friedenreich antigen and the metastatic potential of colon carcinoma cells in a mouse model. Glycoconj J 2001, 18: 895–906.CrossRefPubMed 28. Sikut R, Zhang K, Baeckström D, Hansson GC: Distinct sub-populations of carcinoma-associated MUC1 mucins as detected by the monoclonal antibody 9H8 and antibodies against the sialyl-Lewis a and sialyl-Lewis x epitopes in the circulation of breast-cancer patients. Int J Cancer 1996, 66: 617–623.CrossRefPubMed 29. Basu A, Murthy U, Rodeck U, Herlyn M, Mattes L, Das M: Presence of tumor-associated antigens in epidermal growth factors receptors from different human carcinomas. Cancer Res 1987, 47: 2531–2536.PubMed 30. Hellström I, Garrigues HJ, Garrigues U, Hellström KE: Highly tumor-reactive, internalizing, mouse monoclonal antibodies to Le(y)-related cell surface antigens.
Related posts:
- Cancer Res 2000, 60: 3096–104 PubMed 13 Shimakura Y, Kawada H, A
- Here by comparing cell proliferation status before and after tran
- Cancer Genet Cytogenet 2003, 140: 145–152 CrossRefPubMed 10 Cher
- J Clin Microbiol 1995, 33:1080–1083 PubMed 36 Murrey BE, Singh K
- Emerg Infect Dis 2006,12(5):769–771 PubMed 23 Sahraoui N, Muller